Home » LCT to Acquire Cell Therapy Technology
LCT to Acquire Cell Therapy Technology
March 3, 2005
Biotech Living Cell Technologies (LCT) has signed a letter of intent with California-based Theracyte and Baxter to acquire Theracyte's technology and intellectual property rights on cell therapy. Theracyte's technology and patents cover a family of small, thin, pillow-shaped devices that can be filled with cells and placed under the skin to deliver drugs and therapies to treat disease.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct